Compile Data Set for Download or QSAR
maximum 50k data
Found 472 with Last Name = 'zanaletti' and Initial = 'r'
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  0.437nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603987(US11660293, Example 61)
Affinity DataKi:  0.759nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604048(US11660293, Example 152 | US11660293, Example 154)
Affinity DataKi:  0.871nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604115(US11660293, Example 234 | US11660293, Example 236)
Affinity DataKi:  1.02nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604067(US11660293, Example 175 | US11660293, Example 177)
Affinity DataKi:  1.12nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.17nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604092(US11660293, Example 210 | US11660293, Example 211)
Affinity DataKi:  1.23nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  1.26nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603991(US11660293, Example 89)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604062(US11660293, Example 168 | US11660293, Example 170)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.48nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604066(US11660293, Example 174)
Affinity DataKi:  1.51nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604069(US11660293, Example 178 | US11660293, Example 180)
Affinity DataKi:  1.66nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604132(US11660293, Example 254 | US11660293, Example 256)
Affinity DataKi:  1.78nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604090(US11660293, Example 207 | US11660293, Example 209)
Affinity DataKi:  1.82nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603993(US11660293, Example 93)
Affinity DataKi:  1.95nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604098(US11660293, Example 218 | US11660293, Example 219)
Affinity DataKi:  1.95nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604092(US11660293, Example 210 | US11660293, Example 211)
Affinity DataKi:  2.04nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604048(US11660293, Example 152 | US11660293, Example 154)
Affinity DataKi:  2.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  2.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604087(US11660293, Example 203 | US11660293, Example 205)
Affinity DataKi:  2.57nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604069(US11660293, Example 178 | US11660293, Example 180)
Affinity DataKi:  3.02nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604075(US11660293, Example 187 | US11660293, Example 189)
Affinity DataKi:  3.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604011(US11660293, Example 113 | US11660293, Example 115)
Affinity DataKi:  3.16nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604005(US11660293, Example 106 | US11660293, Example 108)
Affinity DataKi:  3.24nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604062(US11660293, Example 168 | US11660293, Example 170)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604111(US11660293, Example 228 | US11660293, Example 230)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603992(US11660293, Example 91)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604103(US11660293, Example 225 | US11660293, Example 226 ...)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604090(US11660293, Example 207 | US11660293, Example 209)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604115(US11660293, Example 234 | US11660293, Example 236)
Affinity DataKi:  3.55nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604020(US11660293, Example 123 | US11660293, Example 124)
Affinity DataKi:  3.72nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604073(US11660293, Example 184 | US11660293, Example 186)
Affinity DataKi:  3.80nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604067(US11660293, Example 175 | US11660293, Example 177)
Affinity DataKi:  3.89nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604113(US11660293, Example 231 | US11660293, Example 233)
Affinity DataKi:  3.89nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  3.98nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604132(US11660293, Example 254 | US11660293, Example 256)
Affinity DataKi:  4.27nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604098(US11660293, Example 218 | US11660293, Example 219)
Affinity DataKi:  4.68nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604103(US11660293, Example 225 | US11660293, Example 226 ...)
Affinity DataKi:  4.79nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604071(US11660293, Example 181 | US11660293, Example 183)
Affinity DataKi:  4.90nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604119(US11660293, Example 239 | US11660293, Example 241)
Affinity DataKi:  5.37nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603986(US11660293, Example 60)
Affinity DataKi:  5.37nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604121(US11660293, Example 242 | US11660293, Example 244)
Affinity DataKi:  5.62nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604083(US11660293, Example 198 | US11660293, Example 200)
Affinity DataKi:  5.75nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604011(US11660293, Example 113 | US11660293, Example 115)
Affinity DataKi:  6.17nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604113(US11660293, Example 231 | US11660293, Example 233)
Affinity DataKi:  6.31nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604003(US11660293, Example 103 | US11660293, Example 105)
Affinity DataKi:  6.31nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604075(US11660293, Example 187 | US11660293, Example 189)
Affinity DataKi:  6.46nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603996(US11660293, Example 96)
Affinity DataKi:  6.61nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604087(US11660293, Example 203 | US11660293, Example 205)
Affinity DataKi:  6.76nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 472 total ) | Next | Last >>
Jump to: